The actual prevalence may be higher than official documentation suggests, as patients might not report mild thirst symptoms to their healthcare providers
Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study News provided by Acosta Group Apr 14, 2025, 12:05 ET 76% of those who discontinued GLP-1s are eating the same amount or less and many report retaining healthy habits JACKSONVILLE, Fla., April 14, 2025 /PRNewswire/ -- In advance of the National Association of Chain Drug Stores (NACDS) Annual Meeting, Acosta Group is sharing the results of its recent proprietary GLP-1 Shopper Community study, focusing on consumers using the medications specifically to support weight loss
Assessment of free radicals scavenging activity of seven natural pigments and protective effects in AAPH-challenged chicken erythrocytes
Maximising weight loss on GLP-1 medications requires a multi-faceted approach
However, leveraging insurance coverage and the prior authorization assistance from Klinic, numerous patients experience considerably lower expenses compared to the retail price